IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,869,990 | -9.6% | 2,136,223 | +4.4% | 0.01% | 0.0% |
| Q2 2023 | $122,684,601 | -40.6% | 2,046,107 | -51.0% | 0.01% | +11.1% |
| Q1 2023 | $206,614,776 | +80.7% | 4,179,102 | +108.5% | 0.01% | -18.2% |
| Q4 2022 | $114,363,314 | +74.9% | 2,003,913 | +43.8% | 0.01% | +57.1% |
| Q3 2022 | $65,399,000 | +28.9% | 1,393,234 | +2.4% | 0.01% | +40.0% |
| Q2 2022 | $50,755,000 | +4.3% | 1,360,384 | -16.4% | 0.01% | +25.0% |
| Q1 2022 | $48,664,000 | -33.1% | 1,627,555 | -23.3% | 0.00% | -20.0% |
| Q4 2021 | $72,703,000 | -10.1% | 2,123,327 | -2.6% | 0.01% | -16.7% |
| Q3 2021 | $80,849,000 | +68.1% | 2,180,986 | +77.1% | 0.01% | +50.0% |
| Q2 2021 | $48,103,000 | -20.5% | 1,231,844 | -13.3% | 0.00% | -20.0% |
| Q1 2021 | $60,498,000 | – | 1,421,137 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |